British Menopause Society
The British Menopause Society (BMS) educates, informs and guides healthcare professionals in all aspects of post reproductive health.
Primary Care Women’s Health Forum
The Primary Care Women’s Health Forum provides training materials, publications and lectures to support the education of healthcare professionals caring for female patients across the UK.
Progesterone Treatment
Besins Healthcare (UK) Ltd also provides a body identical micronised progesterone which greatly reduces the oestrogen-induced risk of endometrial cancer in women with an intact uterus.2,17,18
Utrogestan 100mg is a micronised progesterone indicated for17
- adjunctive use with oestrogen in postmenopausal women with an intact uterus, as hormone replacement therapy (HRT).
Utrogestan 100mg:
- is a body identical micronised progesterone2,17
- greatly reduces the oestrogen-induced risk of endometrial cancer in women with an intact uterus17,18
- is identical to the hormone produced by the body2,17
- The first micronised progesterone licensed for adjunctive use with oestrogen as HRT17,19-22
Local oestrogen treatment for Vaginal Dryness
Besins Healthcare (UK) Ltd also provides an ultra-low dose oestrogen (estriol) pessary for vaginal atrophy in postmenopausal women which is easily inserted without the need for an applicator.11, 12
Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women11
- An ultra-low dose, estriol pessary that is easily inserted without the need for an applicator, designed with the patient in mind11, 12
- Imvaggis significantly improves the symptoms of vaginal atrophy vs placebo at 12 weeks (p<0.001)13
- The estriol (active ingredient) in Imvaggis is body identical, it is derived from yams and soya and is chemically identical to estriol produced naturally by the body 2, 11, 14
- Imvaggis aligns with recommendations to use the lowest effective dose for treatment of vaginal atrophy15
- Imvaggis is very well tolerated13
Oestrogel Patient Support Website
A website providing information about Oestrogel for patients who have been prescribed Oestrogel.
How to use Oestrogel Pump-Pack leaflet for patients
A leaflet for patients explaining how to use the Oestrogel pump-pack. This leaflet can be passed on to patients who have been prescribed Oestrogel, to instruct them on how to apply it.
Hormone Replacement Therapy (HRT) Journey diary
The HRT Journey Diary is a printable leaflet in which your patients can record how they are feeling and what symptoms they are experiencing over time. The HRT Journey Diary may by a useful tool to use in check-up appointments with your patients.
Women’s Health Concern
Women’s Health Concern (WHC) provides an independent service to advise, reassure and educate women of all ages about their health, wellbeing and lifestyle concerns.
Menopause Matters
An award-winning website which provides up-to-date information about menopausal symptoms and their treatment.
The Menopause Exchange
The Menopause Exchange provides independent advice about the menopause, midlife and postmenopausal health from a panel of experts.
NHS information on the menopause
Information and advice on the menopause from the NHS.
NICE. Menopause information for the public
Advice on the care and support that should be offered for women being treated for symptoms of the menopause.
Request a Visit from a Besins Healthcare Representative
To request a visit from a Besins Healthcare representative, please send an email to information@besins-healthcare.com
Request your Oestrogel Patient Pad
To request your Oestrogel Tear Off Patient Pad please click the button to the right
Request your HRT Products leave piece
To request your HRT Products Leave Piece please click the button to the right
To view Utrogestan 100mg Prescribing Information please click here
For information on how we will use your information please see our Privacy Policy
References:
2. Panay N, Post Reprod Health 2014;20(2):69-72.
11. Imvaggis (estriol) 0.03mg Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/product/10435/smpc Last accessed: May 2021.
12. Data on file IMV/2020/017.
13. Griesser H, et al. Maturitas. 2012;71(4):360-368.
14. Data on file IMV/2020/018.
15. Hamoda H, et al. Post Reprod Health. 2016; 22(4): 165-183.
17. Utrogestan Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/product/352/smpc Last accessed: May 2021.
18. Fournier A, et al. Am J Epidemiol 2014;180(5):508-517.
19. Cyclogest 200mg Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/medicine/15056 Last accessed: May 2021.
20. Cyclogest 400mg Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/product/5569/smpc Last accessed: May 2021.
21. Crinone Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/product/1283/smpc Last accessed: May 2021.
22. Lutigest Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/history/29749 Last accessed: May 2021.
